BiomX Inc. HLSQ
0.53
0.00
0.00%
as of 25 Sep
- Market cap
- $1.5M
- P/E
- 0.0×
Follow HLSQ
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Jun '19 | Dec '18 | Jun '18 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.87 | 2.48 | 1.58 | 4.65 | 6.03 | 8.47 | 13.58 | 1.99 | 24.34 | 0.01 |
Net Debt/EBITDA |
0.13 | 0.43 | 0.20 | 0.80 | 1.46 | 1.82 | 3.71 | 0.49 | 3.24 | 0.00 |
Debt/Assets |
0.00% | 0.00% | 44.70% | 32.67% | 19.53% | 8.38% | 1.34% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 3.63 | 0.71 | 0.32 | 0.10 | 0.01 | 0.01 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.73 | 2.09 | 0.81 | 1.03 | 0.76 | 0.81 | 0.85 | (0.59) | 0.74 | 0.00 |
Capex/Depreciation |
0.04 | 0.02 | (0.03) | (0.04) | (1.34) | (0.46) | (4.13) | — | (0.65) | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| 502.21% | (413.02%) | (216.99%) | (82.59%) | (69.00%) | (42.40%) | (45.97%) | 1.45% | (71.23%) | 0.00% | |
| (147.70%) | (51.94%) | (74.18%) | (45.85%) | (48.84%) | (37.03%) | (44.64%) | 1.53% | (67.20%) | 0.00% | |
ROIC |
0.00% | (439.33%) | 0.00% | (1,051.41%) | 0.00% | (301.47%) | (423.93%) | (0.36%) | (255.63%) | 0.00% |
Return on Tangible Assets |
4,502.36% | (102.48%) | (252.65%) | (83.95%) | (59.11%) | (53.98%) | (25.64%) | 95.05% | (38.97%) | 0.00% |
Average Days of Receivables |
— | — | — | 0.00 | — | — | 0.00 | — | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.04 | 0.05 | 0.00 | 0.10 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% | — |
Free Cash Flow per Share |
(161.14) | (528.28) | (790.19) | (1,859.81) | (2,281.09) | (2,103.80) | (6,296.33) | 0.00 | (10,400.91) | 0.00 |
Cash per Share |
30.38 | 254.85 | 587.56 | 2,184.33 | 4,605.47 | 4,718.26 | 27,471.00 | 0.00 | 36,134.55 | 0.00 |
Shareholders Equity per Share |
(7.98) | 345.46 | 114.11 | 1,340.06 | 3,469.71 | 4,749.50 | 28,152.00 | 0.00 | 38,911.82 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(7.98) | 345.46 | 114.11 | 1,340.06 | 3,469.71 | 4,749.50 | 28,152.00 | 0.00 | 38,911.82 | 0.00 |
Free Cash Flow |
(26.28) | (36.93) | (21.33) | (29.20) | (31.25) | (25.46) | (18.89) | (0.20) | (11.44) | 0.00 |
Working Capital |
(0.80) | 12.25 | 6.46 | 28.94 | 55.60 | 53.51 | 78.31 | 0.37 | 38.25 | (0.04) |
Capital Expenditures |
0.11 | 0.05 | (0.05) | (0.11) | (3.68) | (1.01) | (1.31) | — | (0.14) | 0.00 |
Net Current Asset Value |
(1.51) | 1.44 | (4.32) | 12.39 | 36.18 | 47.77 | 76.87 | (0.13) | 37.36 | (0.04) |
| Other line items | ||||||||||
Quick Ratio |
0.78 | 2.15 | 1.42 | 4.32 | 5.71 | 7.97 | 13.24 | 1.88 | 24.25 | 0.01 |
Depreciation/Fixed assets |
0.00 | 0.52 | 0.37 | 0.62 | 0.48 | 0.98 | 0.17 | — | 0.24 | 0.00 |
Cash ROIC |
(722.42%) | (100.15%) | (83.59%) | (48.26%) | (26.43%) | (22.15%) | (11.58%) | (0.28%) | (14.77%) | 0.00% |
Accounts Receivable Turnover |
— | — | — | 0.00 | — | — | 0.00 | — | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(161.80) | (529.03) | (788.37) | (1,852.99) | (2,012.63) | (2,020.41) | (5,859.00) | 0.00 | (10,276.36) | 0.00 |
Capex per Share |
0.66 | 0.74 | (1.81) | (6.82) | (268.47) | (83.39) | (437.33) | 0.00 | (124.55) | 0.00 |
Average Receivables |
— | — | — | 0.41 | — | — | 0.19 | — | 0.23 | — |
Average Payables |
2.50 | 1.63 | 1.10 | 1.81 | 2.56 | 2.79 | 1.74 | 0.21 | 0.10 | 0.21 |
Average Assets |
24.51 | 34.13 | 35.28 | 61.76 | 74.18 | 81.24 | 46.06 | 22.67 | 22.70 | 0.07 |
Average Common Equity |
(7.21) | 4.29 | 12.06 | 34.29 | 52.50 | 70.96 | 44.73 | 23.90 | 21.41 | 0.01 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Columns are period end dates